Clinical Trial Update: Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating bioabsorbable everolimus-eluting stents for arteriogenic erectile dysfunction related to the internal pudendal artery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriogenic Erectile Dysfunction
• Erectile Dysfunction

Drugs mentioned

• Bioabsorbable Everolimus-Eluting Stent (everolimus-eluting stent)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Impotence, Arteriogenic | Phase 2, Phase 3 | Status: UNKNOWN